Search research articles
Contact Us
Filters
Showing results (561-570 of 579) with videos related to
Page
of 58
Sort By:
The Lancet. Neurology
|
September 20, 2025
2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis
Frederik Barkhof, Daniel S Reich, Jiwon Oh, et al.
Neurology
|
September 2, 2025
Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis Clinic
Brian Renner, Elizabeth Daphne Verter, Martina Absinta, et al.
Science Translational Medicine
|
April 24, 2020
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
Marco A S Baptista, Kalpana Merchant, Ted Barrett, et al.
The Journal of Experimental Medicine
|
February 28, 2022
Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme
Annie Arguello, Cathal S Mahon, Meredith E K Calvert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 28, 2023
The Genetic Drivers of Juvenile, Young, and Early-Onset Parkinson's Disease in India
Shan V Andrews, Prashanth L Kukkle, Ramesh Menon, et al.
Annals of Neurology
|
December 8, 2021
Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis
Antje Bischof, Nico Papinutto, Anisha Keshavan, et al.
Annals of Neurology
|
March 2, 2022
Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS"
Antje Bischof, Nico Papinutto, Anisha Keshavan, et al.
Science Translational Medicine
|
June 8, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease
Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, et al.
AJNR. American Journal of Neuroradiology
|
September 27, 2024
Multicenter Automated Central Vein Sign Detection Performs as Well as Manual Assessment for the Diagnosis of Multiple Sclerosis
A R Manning, V Letchuman, M L Martin, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
A Common PD-Risk <i>GBA1</i> Variant Disrupts LIMP2 Interaction, Impairs Glucocerebrosidase Function, and Drives Lysosomal and Mitochondrial Dysfunction
Oliver B Davis, Jennifer E Kung, Sonnet S Davis, et al.
Page
of 58
Search research articles
Search
Showing results (561-570 of 579) with videos related to
Sort By:
Page
of 58
The Lancet. Neurology
|
September 20, 2025
2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis
Frederik Barkhof, Daniel S Reich, Jiwon Oh, et al.
Neurology
|
September 2, 2025
Frequency and Diagnostic Implications of Paramagnetic Rim Lesions in People Presenting for Diagnosis to a Multiple Sclerosis Clinic
Brian Renner, Elizabeth Daphne Verter, Martina Absinta, et al.
Science Translational Medicine
|
April 24, 2020
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
Marco A S Baptista, Kalpana Merchant, Ted Barrett, et al.
The Journal of Experimental Medicine
|
February 28, 2022
Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme
Annie Arguello, Cathal S Mahon, Meredith E K Calvert, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 28, 2023
The Genetic Drivers of Juvenile, Young, and Early-Onset Parkinson's Disease in India
Shan V Andrews, Prashanth L Kukkle, Ramesh Menon, et al.
Annals of Neurology
|
December 8, 2021
Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis
Antje Bischof, Nico Papinutto, Anisha Keshavan, et al.
Annals of Neurology
|
March 2, 2022
Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS"
Antje Bischof, Nico Papinutto, Anisha Keshavan, et al.
Science Translational Medicine
|
June 8, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease
Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, et al.
AJNR. American Journal of Neuroradiology
|
September 27, 2024
Multicenter Automated Central Vein Sign Detection Performs as Well as Manual Assessment for the Diagnosis of Multiple Sclerosis
A R Manning, V Letchuman, M L Martin, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
A Common PD-Risk <i>GBA1</i> Variant Disrupts LIMP2 Interaction, Impairs Glucocerebrosidase Function, and Drives Lysosomal and Mitochondrial Dysfunction
Oliver B Davis, Jennifer E Kung, Sonnet S Davis, et al.
Page
of 58